Marc S. Sabatine
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Internal Medicine top 0.05%
Papers in
-
- Acute Myocardial Infarction Research 149
- Antiplatelet Therapy and Cardiovascular Diseases 113
- Heart Failure Treatment and Management 51
- Cardiovascular Function and Risk Factors 42
- Surgery 265
- Lipoproteins and Cardiovascular Health 149
- Coronary Interventions and Diagnostics 78
- Co-authors
- David A. Morrow (150 shared papers)Sabina A. Murphy (153 shared papers)Robert P. Giugliano (132 shared papers)Stephen D. Wiviott (66 shared papers)Eugene Braunwald (83 shared papers)Christopher P. Cannon (77 shared papers)Marc P. Bonaca (82 shared papers)Carolyn H. McCabe (30 shared papers)
- Journals
- Journal of the American College of Cardiology (97 papers)Circulation (91 papers)European Heart Journal (39 papers)American Heart Journal (29 papers)JAMA Cardiology (27 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Marc S. Sabatine
490 papers receiving 49.5k citations
Marc S. Sabatine's Hit Papers
Peers
Comparison fields: 5 of 172
- Cardiology and Cardiovascular Medicine 27.9k
- Internal Medicine 3.3k
- Endocrinology, Diabetes and Metabolism 13.3k
- Surgery 22.8k
- Radiology, Nuclear Medicine and Imaging 5.2k
Countries citing papers authored by Marc S. Sabatine
This map shows the geographic impact of Marc S. Sabatine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Sabatine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Sabatine more than expected).
Fields of papers citing papers by Marc S. Sabatine
This network shows the impact of papers produced by Marc S. Sabatine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Sabatine. The network helps show where Marc S. Sabatine may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc S. Sabatine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 512 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2018 | 4267 |
| 2 | 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes Hit paper breakdown → | 2014 | 2655 |
| 3 | SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Hit paper breakdown → | 2018 | 1897 |
| 4 | Cytochrome P-450 Polymorphisms and Response to Clopidogrel Hit paper breakdown → | 2008 | 1725 |
| 5 | Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation Hit paper breakdown → | 2005 | 1302 |
| 6 | Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events Hit paper breakdown → | 2015 | 1091 |
| 7 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Hit paper breakdown → | 2016 | 1046 |
| 8 | The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes Hit paper breakdown → | 2001 | 991 |
| 9 | Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions Hit paper breakdown → | 2016 | 975 |
| 10 | 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary Hit paper breakdown → | 2014 | 901 |
| 11 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Hit paper breakdown → | 2016 | 895 |
| 12 | 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes Hit paper breakdown → | 2014 | 786 |
| 13 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update Hit paper breakdown → | 2013 | 680 |
| 14 | A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease Hit paper breakdown → | 2009 | 667 |
| 15 | 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary Hit paper breakdown → | 2014 | 617 |
| 16 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 585 |
| 17 | Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes Hit paper breakdown → | 2002 | 557 |
| 18 | Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes Hit paper breakdown → | 2005 | 539 |
| 19 | Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Hit paper breakdown → | 2019 | 534 |
| 20 | Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Hit paper breakdown → | 2009 | 500 |
About Marc S. Sabatine
Marc S. Sabatine is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology and Economics and Econometrics, having authored 512 papers that have together received 51.0k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (149 papers), Lipoproteins and Cardiovascular Health (149 papers), Antiplatelet Therapy and Cardiovascular Diseases (113 papers), Diabetes Treatment and Management (101 papers), Coronary Interventions and Diagnostics (78 papers), Heart Failure Treatment and Management (51 papers), Cardiac Imaging and Diagnostics (46 papers) and Cardiovascular Function and Risk Factors (42 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (27.9k citations), Internal Medicine (3.3k citations), Endocrinology, Diabetes and Metabolism (13.3k citations), Surgery (22.8k citations) and Radiology, Nuclear Medicine and Imaging (5.2k citations). Marc S. Sabatine has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David A. Morrow, Sabina A. Murphy, Robert P. Giugliano, Stephen D. Wiviott, Eugene Braunwald, Christopher P. Cannon, Marc P. Bonaca, Carolyn H. McCabe, Eugene Braunwald and Deepak L. Bhatt. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, European Heart Journal, American Heart Journal and JAMA Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.